
Audio By Carbonatix
Mild asthma might not need to be treated every day, say US researchers.A "preventer" inhaler containing corticosteroid is part of many asthma sufferers' daily routine, but it can result in reduced growth and children often forget to take it.This study, published in The Lancet, shows that it is possible to manage the symptoms without a daily dose.Asthma UK said daily treatment was still the most effective, and concerned patients should speak to their doctor.The disease causes inflammation of the tubes which carry air to and from the lungs. If they become irritated, then the airways narrow, sticky mucus is produced and breathing becomes difficult.More than 5 million people in the UK are being treated for the illness and Asthma UK estimates 1.1 million have asthma which is mild and under control.Missing dosesResearchers at the University of Arizona believe there is a problem with the way the disease is managed.Two types of inhalers are used: "relievers" which are used when breathing is difficult and "preventers" which are taken every morning and evening.However, the researchers said that many children stop taking the daily medication if their symptoms disappear.Professor Fernando Martinez, from the University of Arizona, told the BBC: "If you have a daily drug and a very significant number are not taking it, then that tells you it's a losing strategy.""We want to find something which is more child- and parent-friendly as well as avoid the growth effect."In all, 288 children and teenagers with mild and persistent asthma took part in the 44-week trial.The study showed that taking corticosteroids twice a day was still the most effective treatment, However, those taking the medication grew by 1.1cm (0.5in) less than children not taking the drug during the trial.Potent combinationImportantly, asthma was also managed without daily treatment if the corticosteroids were combined with the "reliever" inhaler.This eliminated the effect on growth and the researchers say it would be an easier form of treatment for children.Further clinical trials will be needed to verify the results.Professor Martinez said: "I'm continuing to recommend daily corticosteroid to my patients, but I know some of them will not take it."Asthma UK said the study confirmed that daily inhaled corticosteroids were the most effective treatment.Dr Samantha Walker, executive director of research and policy at Asthma UK, said: "We know that long-term adherence to medicine treatment plans can be difficult, particularly when a child's asthma seems to be under control."The use of combined 'preventer' and 'reliever' medicines as rescue therapy appears to be superior to 'reliever' inhalers alone and offers a new 'step-down' approach to the management of mild, well-controlled asthma in children and young people who find it difficult to adhere to long-term daily treatment with inhaled steroids."Many parents have concerns about their child's steroid intake. However, research shows that children on low daily doses of 'preventer' medicines show no difference in growth. At higher doses, the picture is less clear. For all children, treatment plans should be reviewed at least every six months."If you have any concerns about your asthma treatment, Asthma UK recommends you speak to your doctor or asthma nurse."Source: BBC
DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by Readers and Contributors on this platform do not necessarily represent the views or policy of Multimedia Group Limited.
Tags:
DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by Readers and Contributors on this platform do not necessarily represent the views or policy of Multimedia Group Limited.
Latest Stories
-
NACOC concludes four-day anti-drug operation in Eastern, Greater Accra regions
16 minutes -
Cedi dips further as external shocks intensify; one dollar equals GH¢11.70 at forex bureaus
28 minutes -
Sampa chieftaincy dispute: Sammordua dragged to court for contempt
35 minutes -
Okyere Baafi calls for suspension of Publican AI system over ‘serious flaws’
38 minutes -
Fuel fraud: OSP uncovers “secret collusion” between 5 oil companies and 3 state entities
44 minutes -
VIP Transport defends fare increase over rising fuel and maintenance costs
60 minutes -
LGBTQ+ issues not a priority for Ghanaians – Felix Kwakye Ofosu
1 hour -
Kwakye Ofosu rejects NPP Minority’s call for apology over anti-LGBTQ bill
1 hour -
Music giant Universal gets $64bn takeover offer
2 hours -
NPP criticism of anti-LGBTQ Bill ‘nothing more than political posturing’ — Kwakye Ofosu
2 hours -
Joy FM was birthed over a bowl of fufu’ – Tommy Annan-Forson shares interesting story
2 hours -
World Athletics to introduce standalone World Marathon Championships from 2030
2 hours -
Africa’s voice in global journalism grows as funding, AI and misinformation shape newsrooms
2 hours -
First Atlantic Bank holds Annual General Meeting, reports strong growth and bold outlook for 2026
2 hours -
Ghanaian-founded fintech WeWire secures Canadian PSP license to bridge African, global payments
2 hours